Eradication of Cryptosporidia and Microsporidia Following Successful Antiretroviral Therapy
Authors:
- Benson Joan O.BOBenson Joan O.
- Kay McGheeKMKay McGhee
- Paul CoplanPCPaul Coplan
- Carl GrunfeldCGCarl Grunfeld
- Michael RobertsonMRMichael Robertson
- Kimberly Goodnow BrodoviczKBKimberly Goodnow Brodovicz
- Eve SlaterESEve Slater
- 1 October 2000
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 25 (2) , 124-129
Abstract
Context:Fat redistribution (FR) occurring alone or in association with hyperlipidemia has been associated with protease inhibitors (PI) and nucleoside reverse transcriptase inhibitors (NRTIs); however, the relationship between FR features, relationship of FR to hyperlipidemia, and pathogenesis of FR is unknown. Objective:To characterize the spectrum of FR, assess relationships among FR features, determine trends in occurrence of FR, and determine relationship of FR to hyperlipidemia. Design:Review of postmarketing indinavir reports of FR in Merck & Co. Inc.'s database. Setting and Participants:282 reports of FR among HIV-positive patients taking indinavir submitted through the passive postmarketing system to Merck through February 23, 1998. Results:282 FR reports were compared across 3 groups: fat accumulation (FA) only, FA with peripheral wasting (FA with PW), and peripheral wasting only (PWO). Of 282 reports, 56% (159 of 282) had FA only, 22% (63 of 282) had FA with PW, and 21% (60 of 282) had PWO. The proportions of reports of PWO was higher in men, whereas the proportion of reports of FA was higher in women. Blood lipids were provided in 93 of 282 reports; were elevated in 69 of 93, and were normal in 24 of 93 reports. Proportions of hyperlipidemia and hypertriglyceridemia reports were significantly higher in the PWO group versus FA only group (p = .024 and .003, respectively) and versus FA with/without PW groups (p = .038 and .005, respectively). Weight gain was more frequently reported in those with FA (100%) or FA with PW (68%), whereas weight loss was usually reported in those with PWO (83%). In all, 98% of patients reporting FR on indinavir for whom a concomitant drug history was available were also taking lamivudine, stavudine, or both. A higher proportion of patients reporting PWO (34 of 60; 56.7%) versus FA (42 of 159; 26.4%) only took both lamivudine and stavudine. Conclusions:Differences observed from analysis of cases in clinical features, gender, weight change, concomitant medications, and presence of hyperlipidemia among the three groups of FR cases reported to Merck suggests that PWO may be a distinct entity from other features of FR. The data suggest that certain antiretroviral combinations predispose HIV persons to development of FR. Address correspondence and reprint requests to Joan O. Benson, M.D., M.P.H., Merck & Company, Inc., 1 Merck Drive, P.O. Box 100, Whitehouse Station, NJ 08889, U.S.A; e-mail: [email protected] Carl Grunfeld, M.D., Ph.D., is a consultant to Merck & Company, Inc. Manuscript received May 10, 2000; accepted June 28, 2000. © 2000 Lippincott Williams & Wilkins, Inc.Keywords
This publication has 20 references indexed in Scilit:
- Cryptosporidiosis: eradication or suppression with combination antiretroviral therapy?AIDS, 1999
- Correlation between markers of strain variation in Cryptosporidium parvum: Evidence of clonalityParasitology International, 1998
- Modification of the clinical course of intestinal microsporidiosis in acquired immunodeficiency syndrome patients by immune status and anti-human immunodeficiency virus therapy.The American Journal of Tropical Medicine and Hygiene, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapyThe Lancet, 1998
- Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosisInternational Journal of STD & AIDS, 1997
- Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients.Gut, 1996
- Gastrointestinal manifestations of HIV infectionThe Lancet, 1996
- Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique.Journal of Clinical Pathology, 1993
- Light and electron microscopic appearances of pathological changes in HIV gut infectionBailliere's Clinical Gastroenterology, 1990